LITHIUM

LITHIUM was reported 25402 times

These side effects are most commonly reported by patients taking LITHIUM:

# Side effect Count
0 DRUG INEFFECTIVE 2333
1 TOXICITY TO VARIOUS AGENTS 2305
2 OFF LABEL USE 1631
3 DRUG INTERACTION 1612
4 TREMOR 1531
5 NAUSEA 1423
6 WEIGHT INCREASED 1214
7 FATIGUE 1093
8 VOMITING 1083
9 DEPRESSION 1017
10 ANXIETY 998
11 INSOMNIA 945
12 SOMNOLENCE 945
13 SUICIDAL IDEATION 926
14 DIZZINESS 849
15 CONFUSIONAL STATE 827
16 CONDITION AGGRAVATED 826
17 DIARRHOEA 803
18 MANIA 793
19 HEADACHE 747
20 COMPLETED SUICIDE 739
21 OVERDOSE 730
22 PSYCHOTIC DISORDER 662
23 SUICIDE ATTEMPT 661
24 NEUROLEPTIC MALIGNANT SYNDROME 625
25 ASTHENIA 621
26 ACUTE KIDNEY INJURY 620
27 FEELING ABNORMAL 610
28 PRODUCT USE IN UNAPPROVED INDICATION 610
29 PNEUMONIA 604
30 AGITATION 603
31 MALAISE 574
32 FALL 558
33 SCHIZOPHRENIA 552
34 DYSPNOEA 522
35 HYPERTENSION 504
36 SEDATION 498
37 PAIN 493
38 GAIT DISTURBANCE 478
39 MEMORY IMPAIRMENT 478
40 WEIGHT DECREASED 471
41 PYREXIA 456
42 IRRITABILITY 448
43 NEUTROPENIA 438
44 SEROTONIN SYNDROME 424
45 BIPOLAR DISORDER 423
46 CONSTIPATION 413
47 AGGRESSION 412
48 EXTRAPYRAMIDAL DISORDER 400
49 AKATHISIA 385
50 INTENTIONAL OVERDOSE 385
51 HYPERHIDROSIS 384
52 SEIZURE 378
53 DIABETES MELLITUS 371
54 DYSARTHRIA 368
55 RASH 364
56 HYPOTENSION 359
57 DEATH 346
58 TREATMENT NONCOMPLIANCE 343
59 HYPOMANIA 341
60 TACHYCARDIA 338
61 DYSKINESIA 334
62 MENTAL DISORDER 328
63 VISION BLURRED 328
64 COGNITIVE DISORDER 326
65 DELIRIUM 319
66 ARTHRALGIA 318
67 HALLUCINATION 318
68 LOSS OF CONSCIOUSNESS 318
69 LEUKOPENIA 310
70 RENAL FAILURE 310
71 TARDIVE DYSKINESIA 310
72 DISTURBANCE IN ATTENTION 308
73 NEPHROGENIC DIABETES INSIPIDUS 304
74 ABNORMAL BEHAVIOUR 303
75 DEHYDRATION 303
76 HALLUCINATION, AUDITORY 302
77 BALANCE DISORDER 300
78 DRUG ABUSE 287
79 PAIN IN EXTREMITY 287
80 RESTLESSNESS 287
81 URINARY TRACT INFECTION 287
82 ABDOMINAL PAIN 286
83 PARKINSONISM 284
84 DISORIENTATION 278
85 CHOLELITHIASIS 276
86 LETHARGY 272
87 DECREASED APPETITE 265
88 ELECTROCARDIOGRAM QT PROLONGED 265
89 HEPATIC ENZYME INCREASED 262
90 SPEECH DISORDER 262
91 FOETAL EXPOSURE DURING PREGNANCY 261
92 OBSESSIVE-COMPULSIVE DISORDER 260
93 ATAXIA 258
94 CHEST PAIN 253
95 DYSPHAGIA 253
96 CHRONIC KIDNEY DISEASE 251
97 CATATONIA 249
98 MUSCLE SPASMS 249
99 HOSPITALISATION 248
100 GASTROOESOPHAGEAL REFLUX DISEASE 247
101 ANTIPSYCHOTIC DRUG LEVEL INCREASED 245
102 WITHDRAWAL SYNDROME 245
103 DRUG DOSE OMISSION 244
104 SLEEP DISORDER 243
105 DEPRESSED LEVEL OF CONSCIOUSNESS 241
106 OEDEMA PERIPHERAL 240
107 DEPRESSED MOOD 239
108 WHITE BLOOD CELL COUNT DECREASED 239
109 PARANOIA 235
110 HYPOAESTHESIA 232
111 MENTAL STATUS CHANGES 232
112 MUSCULAR WEAKNESS 232
113 AMNESIA 231
114 HYPOTHYROIDISM 231
115 ENCEPHALOPATHY 229
116 INTENTIONAL PRODUCT MISUSE 229
117 PRURITUS 227
118 BLOOD CREATININE INCREASED 223
119 ALOPECIA 222
120 MUSCULOSKELETAL STIFFNESS 218
121 BACK PAIN 217
122 DELUSION 216
123 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 214
124 DRUG HYPERSENSITIVITY 213
125 BLOOD PRESSURE INCREASED 211
126 INCORRECT DOSE ADMINISTERED 211
127 PRODUCT USE ISSUE 210
128 COMA 209
129 TYPE 2 DIABETES MELLITUS 209
130 SALIVARY HYPERSECRETION 205
131 ANGER 204
132 RENAL IMPAIRMENT 204
133 BLOOD CREATINE PHOSPHOKINASE INCREASED 200
134 BRADYCARDIA 199
135 PALPITATIONS 197
136 CARDIAC ARREST 196
137 BLOOD BILIRUBIN INCREASED 195
138 DYSPEPSIA 195
139 MYALGIA 195
140 MIGRAINE 194
141 LEUKOCYTOSIS 192
142 MENTAL IMPAIRMENT 192
143 MUSCLE RIGIDITY 191
144 ABDOMINAL DISCOMFORT 190
145 HEPATOTOXICITY 190
146 PARAESTHESIA 190
147 WHITE BLOOD CELL COUNT INCREASED 190
148 DRUG WITHDRAWAL SYNDROME 188
149 OBESITY 186
150 ADVERSE DRUG REACTION 185
151 ABDOMINAL PAIN UPPER 183
152 MYOCARDITIS 183
153 RHABDOMYOLYSIS 183
154 HYPERNATRAEMIA 182
155 COUGH 181
156 DRUG LEVEL INCREASED 181
157 ANAEMIA 180
158 MYOCLONUS 178
159 WHEEZING 176
160 NEUROTOXICITY 175
161 DRY MOUTH 174
162 APHASIA 173
163 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 173
164 PSYCHOMOTOR HYPERACTIVITY 173
165 TREATMENT FAILURE 172
166 CONTUSION 170
167 NEUTROPHIL COUNT INCREASED 169
168 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 167
169 INTENTIONAL SELF-INJURY 166
170 JAUNDICE CHOLESTATIC 166
171 CRYING 165
172 EUPHORIC MOOD 165
173 MUSCLE TWITCHING 165
174 AFFECTIVE DISORDER 161
175 BLOOD GLUCOSE INCREASED 160
176 CARDIO-RESPIRATORY ARREST 159
177 DRUG INTOLERANCE 159
178 INCREASED APPETITE 159
179 NEUTROPHIL COUNT DECREASED 159
180 SCHIZOAFFECTIVE DISORDER 157
181 EMOTIONAL DISTRESS 156
182 STRESS 156
183 HALLUCINATION, VISUAL 155
184 PLATELET COUNT DECREASED 155
185 VISUAL IMPAIRMENT 155
186 PANIC ATTACK 154
187 PRODUCT DOSE OMISSION ISSUE 154
188 NEUROPATHY PERIPHERAL 153
189 URINARY INCONTINENCE 153
190 COVID-19 152
191 PULMONARY EMBOLISM 152
192 VERTIGO 150
193 DRUG DEPENDENCE 147
194 PRESCRIBED OVERDOSE 146
195 MOOD SWINGS 145
196 DYSTONIA 144
197 ADVERSE EVENT 143
198 ALANINE AMINOTRANSFERASE INCREASED 143
199 HYPERSOMNIA 143
200 CHILLS 141
201 DISEASE RECURRENCE 141
202 ABDOMINAL DISTENSION 140
203 FEELING HOT 140
204 MATERNAL EXPOSURE DURING PREGNANCY 140
205 THROMBOCYTOPENIA 140
206 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 140
207 HYPERCALCAEMIA 139
208 MYOCARDIAL INFARCTION 139
209 SYNCOPE 139
210 THINKING ABNORMAL 138
211 EXPOSURE DURING PREGNANCY 137
212 GENERAL PHYSICAL HEALTH DETERIORATION 136
213 NIGHTMARE 136
214 HYPERPARATHYROIDISM 135
215 RESPIRATORY FAILURE 135
216 CONVULSION 134
217 DYSGEUSIA 134
218 ALTERED STATE OF CONSCIOUSNESS 132
219 HEART RATE INCREASED 132
220 NERVOUSNESS 132
221 HAEMOGLOBIN DECREASED 131
222 HYPOPHAGIA 131
223 BLOOD CHOLESTEROL INCREASED 130
224 POOR QUALITY SLEEP 129
225 PERIPHERAL SWELLING 127
226 SEPSIS 127
227 ANTIPSYCHOTIC DRUG LEVEL BELOW THERAPEUTIC 125
228 APATHY 125
229 CARDIAC MURMUR 125
230 HYPONATRAEMIA 124
231 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 124
232 HYPERSENSITIVITY 123
233 URINARY RETENTION 122
234 AGRANULOCYTOSIS 121
235 BIPOLAR I DISORDER 121
236 DIABETES INSIPIDUS 121
237 INJECTION SITE PAIN 121
238 UNRESPONSIVE TO STIMULI 121
239 COORDINATION ABNORMAL 120
240 HYPERGLYCAEMIA 120
241 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 119
242 PSORIASIS 119
243 SLEEP APNOEA SYNDROME 118
244 URTICARIA 117
245 DEEP VEIN THROMBOSIS 116
246 MEDICATION ERROR 116
247 RESTLESS LEGS SYNDROME 116
248 THERAPY NON-RESPONDER 116
249 MOOD ALTERED 115
250 MOBILITY DECREASED 114
251 MOVEMENT DISORDER 114
252 ERYTHEMA 113
253 HYPOGLYCAEMIA 113
254 CEREBROVASCULAR ACCIDENT 111
255 PANCREATITIS 111
256 HYPERPROLACTINAEMIA 110
257 INFLUENZA LIKE ILLNESS 109
258 ASPARTATE AMINOTRANSFERASE INCREASED 108
259 CELLULITIS 107
260 INFECTION 107
261 ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC 106
262 DROOLING 106
263 RHINITIS ALLERGIC 106
264 BODY TEMPERATURE INCREASED 105
265 EMOTIONAL DISORDER 105
266 CHEST DISCOMFORT 104
267 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 103
268 NASOPHARYNGITIS 103
269 GRANULOCYTOPENIA 102
270 HYPERREFLEXIA 102
271 SARCOIDOSIS 102
272 FLUSHING 101
273 RENAL FAILURE ACUTE 101
274 BRONCHIECTASIS 100
275 DRUG RESISTANCE 100
276 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 100
277 METABOLIC ACIDOSIS 100
278 NASAL POLYPS 100
279 NECK PAIN 100
280 POLLAKIURIA 100
281 THERAPEUTIC RESPONSE DECREASED 100
282 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 99
283 FEAR 99
284 LUNG NEOPLASM MALIGNANT 99
285 TOTAL LUNG CAPACITY INCREASED 99
286 LYMPHOCYTE COUNT DECREASED 98
287 CARDIAC DISORDER 97
288 INFLUENZA 97
289 RENAL DISORDER 97
290 SINUS TACHYCARDIA 97
291 MAJOR DEPRESSION 96
292 NERVOUS SYSTEM DISORDER 96
293 AFFECT LABILITY 95
294 BLOOD TRIGLYCERIDES INCREASED 95
295 PRODUCT QUALITY ISSUE 94
296 DYSLIPIDAEMIA 93
297 JOINT SWELLING 93
298 RESPIRATORY ARREST 92
299 MIDDLE INSOMNIA 91
300 THERAPY CESSATION 91
301 BLOOD PROLACTIN INCREASED 90
302 C-REACTIVE PROTEIN INCREASED 90
303 EOSINOPHILIA 90
304 SWELLING FACE 89
305 THERAPEUTIC AGENT TOXICITY 88
306 ABNORMAL DREAMS 87
307 BLOOD PRESSURE DECREASED 87
308 INJURY 87
309 THERAPEUTIC RESPONSE UNEXPECTED 86
310 ERECTILE DYSFUNCTION 85
311 PRODUCT SUBSTITUTION ISSUE 85
312 DELUSION OF GRANDEUR 84
313 DRUG EFFECT DECREASED 84
314 GASTROINTESTINAL DISORDER 84
315 PNEUMONIA ASPIRATION 84
316 END STAGE RENAL DISEASE 83
317 GENERALISED TONIC-CLONIC SEIZURE 83
318 OROPHARYNGEAL PAIN 83
319 OEDEMA 82
320 POLYURIA 81
321 SEXUAL DYSFUNCTION 81
322 UNEVALUABLE EVENT 81
323 GYNAECOMASTIA 80
324 INTENTIONAL PRODUCT USE ISSUE 80
325 TINNITUS 80
326 DISEASE PROGRESSION 79
327 POISONING 79
328 ROAD TRAFFIC ACCIDENT 79
329 SUSPECTED SUICIDE 79
330 TROPONIN INCREASED 79
331 DISCOMFORT 78
332 TOXIC ENCEPHALOPATHY 78
333 BRUXISM 77
334 HYPERTHERMIA 77
335 LIBIDO INCREASED 77
336 POISONING DELIBERATE 77
337 SOPOR 77
338 DISINHIBITION 76
339 HEAD INJURY 76
340 ILLNESS 76
341 NEPHROPATHY 76
342 HYPERTHYROIDISM 75
343 NASAL CONGESTION 75
344 CATARACT 74
345 DIABETIC KETOACIDOSIS 74
346 LOWER RESPIRATORY TRACT INFECTION 74
347 HOMICIDAL IDEATION 73
348 POLYDIPSIA 73
349 THIRST 73
350 ACNE 72
351 CARDIOMYOPATHY 72
352 CONTRAINDICATED PRODUCT ADMINISTERED 71
353 UNDERDOSE 71
354 ASTHMA 70
355 BEHAVIOUR DISORDER 70
356 DYSPHONIA 70
357 EATING DISORDER 70
358 INTESTINAL OBSTRUCTION 70
359 AMENORRHOEA 68
360 HYPERAMMONAEMIA 68
361 MUCOSAL INFLAMMATION 68
362 ORTHOSTATIC HYPOTENSION 68
363 RIB FRACTURE 68
364 TACHYPNOEA 68
365 HEART RATE DECREASED 67
366 IMPULSIVE BEHAVIOUR 67
367 PANCYTOPENIA 67
368 TUBULOINTERSTITIAL NEPHRITIS 67
369 ACCIDENTAL OVERDOSE 66
370 CONCUSSION 66
371 BRONCHITIS 65
372 OSTEOPOROSIS 65
373 PERSONALITY DISORDER 65
374 PLEUROTHOTONUS 65
375 RENAL CYST 65
376 PREMATURE BABY 64
377 SHOCK 64
378 PSYCHIATRIC SYMPTOM 63
379 ARRHYTHMIA 62
380 ENURESIS 62
381 HOSTILITY 62
382 THERAPEUTIC PRODUCT EFFECT VARIABLE 62
383 THYROID DISORDER 62
384 TRISMUS 62
385 CARDIAC FAILURE 61
386 HYPOTHERMIA 61
387 HOT FLUSH 60
388 HYPOKALAEMIA 60
389 PARALYSIS 60
390 STEVENS-JOHNSON SYNDROME 60
391 TACHYPHRENIA 60
392 ATRIAL FIBRILLATION 59
393 BRAIN INJURY 59
394 POST-TRAUMATIC STRESS DISORDER 59
395 CLONUS 58
396 LIVER INJURY 58
397 PRODUCT PRESCRIBING ERROR 58
398 SWELLING 58
399 ANHEDONIA 57
400 BURNING SENSATION 57
401 DISSOCIATION 57
402 HYPOTONIA 57
403 ILL-DEFINED DISORDER 57
404 IMPAIRED WORK ABILITY 57
405 NEPHROPATHY TOXIC 57
406 RENAL FAILURE CHRONIC 57
407 SARS-COV-2 TEST POSITIVE 57
408 DIABETES MELLITUS INADEQUATE CONTROL 56
409 GALACTORRHOEA 56
410 PRIAPISM 56
411 WRONG TECHNIQUE IN DRUG USAGE PROCESS 56
412 ARTHRITIS 55
413 EPILEPSY 55
414 GAMBLING DISORDER 55
415 INTENTIONAL DRUG MISUSE 55
416 OCULOGYRIC CRISIS 55
417 PSYCHIATRIC DECOMPENSATION 55
418 RESPIRATORY DISTRESS 55
419 ACTIVITIES OF DAILY LIVING IMPAIRED 54
420 HAEMATOCRIT DECREASED 54
421 INCONTINENCE 54
422 LYMPHADENOPATHY 54
423 PARKINSON^S DISEASE 54
424 SINUSITIS 54
425 SOCIAL AVOIDANT BEHAVIOUR 54
426 SOMATIC SYMPTOM DISORDER 54
427 THERAPY INTERRUPTED 54
428 DRY SKIN 53
429 GLOMERULAR FILTRATION RATE DECREASED 53
430 LYMPHOCYTE COUNT ABNORMAL 53
431 PSYCHOTIC SYMPTOM 53
432 RHINALGIA 53
433 TRANSAMINASES INCREASED 53
434 ATRIAL SEPTAL DEFECT 52
435 DRUG TOXICITY 52
436 FEELING JITTERY 52
437 NEUTROPHILIA 52
438 NO ADVERSE EVENT 52
439 OXYGEN SATURATION DECREASED 52
440 THERAPY PARTIAL RESPONDER 52
441 AUTONOMIC NERVOUS SYSTEM IMBALANCE 51
442 BRADYKINESIA 51
443 DIPLOPIA 51
444 DRUG LEVEL DECREASED 51
445 EYE PAIN 51
446 GASTROINTESTINAL HAEMORRHAGE 51
447 ILEUS 51
448 STUPOR 51
449 CARDIAC FAILURE CONGESTIVE 50
450 DRUG ADMINISTRATION ERROR 50
451 HEPATIC STEATOSIS 50
452 STATUS EPILEPTICUS 50
453 GESTATIONAL DIABETES 49
454 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 49
455 LIVER FUNCTION TEST ABNORMAL 49
456 PRODUCT DOSE OMISSION 49
457 DYSURIA 48
458 ELECTROCARDIOGRAM ABNORMAL 48
459 EYE MOVEMENT DISORDER 48
460 GAIT INABILITY 48
461 LIP SWELLING 48
462 LOGORRHOEA 48
463 METABOLIC SYNDROME 48
464 NEUROLOGICAL SYMPTOM 48
465 RHINORRHOEA 48
466 SKIN DISCOLOURATION 48
467 VIRAL INFECTION 48
468 DEPRESSIVE SYMPTOM 47
469 DYSSTASIA 47
470 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 47
471 HAEMORRHAGE 47
472 HYPERLIPIDAEMIA 47
473 HYPERVENTILATION 47
474 MULTIPLE SCLEROSIS RELAPSE 47
475 RENAL INJURY 47
476 TRANSIENT ISCHAEMIC ATTACK 47
477 ECONOMIC PROBLEM 46
478 GOITRE 46
479 LIVER DISORDER 46
480 SUBSTANCE ABUSE 46
481 DEMENTIA 45
482 DRUG EFFECT INCOMPLETE 45
483 DRUG LEVEL ABOVE THERAPEUTIC 45
484 OSTEOPENIA 45
485 SELF-INJURIOUS IDEATION 45
486 SOFT TISSUE INJURY 45
487 STERNAL FRACTURE 45
488 ACCIDENTAL EXPOSURE TO PRODUCT 44
489 BUNDLE BRANCH BLOCK RIGHT 44
490 HYPOKINESIA 44
491 MYDRIASIS 44
492 OROMANDIBULAR DYSTONIA 44
493 POST-TRAUMATIC NECK SYNDROME 44
494 SLUGGISHNESS 44
495 DRUG LEVEL BELOW THERAPEUTIC 43
496 DRUG-INDUCED LIVER INJURY 43
497 INFLAMMATION 43
498 METABOLIC DISORDER 43
499 MULTIPLE SCLEROSIS 43
500 NYSTAGMUS 43
501 BLOOD GLUCOSE DECREASED 42
502 BRADYPHRENIA 42
503 CHOKING 42
504 EYE DISORDER 42
505 INJECTION SITE REACTION 42
506 NIGHT SWEATS 42
507 PRESSURE OF SPEECH 42
508 SINUS BRADYCARDIA 42
509 ANTIPSYCHOTIC DRUG LEVEL DECREASED 41
510 EPISTAXIS 41
511 GASTRIC DISORDER 41
512 HUNGER 41
513 HYPERTONIA 41
514 HYPOXIA 41
515 OSTEOARTHRITIS 41
516 PLEURAL EFFUSION 41
517 SWOLLEN TONGUE 41
518 BLISTER 40
519 BLOOD UREA INCREASED 40
520 BONE PAIN 40
521 DECREASED ACTIVITY 40
522 DISABILITY 40
523 FEELING COLD 40
524 HAEMATOCHEZIA 40
525 LEFT VENTRICULAR DYSFUNCTION 40
526 RASH MACULO-PAPULAR 40
527 RECTAL HAEMORRHAGE 40
528 RETCHING 40
529 ANGIOEDEMA 39
530 DEVICE ISSUE 39
531 FLUID RETENTION 39
532 GLYCOSYLATED HAEMOGLOBIN INCREASED 39
533 HALLUCINATIONS, MIXED 39
534 HYPERKALAEMIA 39
535 HYPERPHAGIA 39
536 INTERVERTEBRAL DISC PROTRUSION 39
537 NEOPLASM PROGRESSION 39
538 POTENTIATING DRUG INTERACTION 39
539 PULMONARY OEDEMA 39
540 RASH PRURITIC 39
541 RHEUMATOID ARTHRITIS 39
542 TONGUE DISORDER 39
543 TYPE 1 DIABETES MELLITUS 39
544 BLOOD SODIUM DECREASED 38
545 DECREASED INTEREST 38
546 HEPATITIS 38
547 HERPES ZOSTER 38
548 HYPOVOLAEMIA 38
549 NEEDLE ISSUE 38
550 NOCTURIA 38
551 RED BLOOD CELL COUNT DECREASED 38
552 SKIN EXFOLIATION 38
553 THROMBOSIS 38
554 UPPER RESPIRATORY TRACT INFECTION 38
555 ARTHROPATHY 37
556 BLOOD THYROID STIMULATING HORMONE DECREASED 37
557 BONE DENSITY DECREASED 37
558 CEREBELLAR ATROPHY 37
559 DRUG WITHDRAWAL SYNDROME NEONATAL 37
560 DYSPHEMIA 37
561 GRANDIOSITY 37
562 IMPAIRED DRIVING ABILITY 37
563 MULTIPLE ORGAN DYSFUNCTION SYNDROME 37
564 MUTISM 37
565 SKIN DISORDER 37
566 ANTICHOLINERGIC SYNDROME 36
567 DIABETIC NEUROPATHY 36
568 DRUG EXPOSURE DURING PREGNANCY 36
569 DRY EYE 36
570 GAMMA-GLUTAMYLTRANSFERASE INCREASED 36
571 GLUCOSE TOLERANCE IMPAIRED 36
572 HAEMATEMESIS 36
573 LONG QT SYNDROME 36
574 OVERWEIGHT 36
575 SENSORY DISTURBANCE 36
576 SPLENOMEGALY 36
577 THERAPEUTIC RESPONSE SHORTENED 36
578 BLOOD ALKALINE PHOSPHATASE INCREASED 35
579 BRUGADA SYNDROME 35
580 COGWHEEL RIGIDITY 35
581 DYSPHORIA 35
582 EOSINOPHIL COUNT DECREASED 35
583 JUDGEMENT IMPAIRED 35
584 MUSCLE CONTRACTIONS INVOLUNTARY 35
585 OPPOSITIONAL DEFIANT DISORDER 35
586 PERICARDIAL EFFUSION 35
587 PERICARDITIS 35
588 SOMNAMBULISM 35
589 ABASIA 34
590 BEDRIDDEN 34
591 CARDIOMEGALY 34
592 CEREBRAL ATROPHY 34
593 COMPULSIVE SHOPPING 34
594 FEELING DRUNK 34
595 FIBROMYALGIA 34
596 HYPERTENSIVE CRISIS 34
597 IMPAIRED GASTRIC EMPTYING 34
598 METABOLIC ENCEPHALOPATHY 34
599 MICTURITION URGENCY 34
600 MOTOR DYSFUNCTION 34
601 PANCREATITIS ACUTE 34
602 PLATELET COUNT INCREASED 34
603 SINUS NODE DYSFUNCTION 34
604 VISUAL ACUITY REDUCED 34
605 APNOEA 33
606 CYSTITIS 33
607 DEMENTIA ALZHEIMER^S TYPE 33
608 DIABETIC COMA 33
609 ELECTROCARDIOGRAM T WAVE ABNORMAL 33
610 FLATULENCE 33
611 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 33
612 LIVE BIRTH 33
613 MUSCULOSKELETAL PAIN 33
614 SKIN ULCER 33
615 SUICIDAL BEHAVIOUR 33
616 TOOTH LOSS 33
617 ACUTE PSYCHOSIS 32
618 ACUTE RESPIRATORY FAILURE 32
619 AMMONIA INCREASED 32
620 CARDIOTOXICITY 32
621 DECREASED EYE CONTACT 32
622 DEVICE MALFUNCTION 32
623 INJECTION SITE BRUISING 32
624 INJECTION SITE HAEMORRHAGE 32
625 IRRITABLE BOWEL SYNDROME 32
626 LABORATORY TEST ABNORMAL 32
627 LEUKAEMIA 32
628 MUSCLE TIGHTNESS 32
629 NEPHROLITHIASIS 32
630 PARADOXICAL DRUG REACTION 32
631 PRODUCT PRESCRIBING ISSUE 32
632 PROTEINURIA 32
633 RASH ERYTHEMATOUS 32
634 THERAPEUTIC PRODUCT EFFECT DECREASED 32
635 VITAMIN D DEFICIENCY 32
636 ABNORMAL WEIGHT GAIN 31
637 BLOOD THYROID STIMULATING HORMONE INCREASED 31
638 CHOREOATHETOSIS 31
639 FAECALOMA 31
640 HAEMODIALYSIS 31
641 HAEMODYNAMIC INSTABILITY 31
642 LACTIC ACIDOSIS 31
643 PERSONALITY CHANGE 31
644 PULMONARY CONGESTION 31
645 RASH GENERALISED 31
646 SURGERY 31
647 TOOTH FRACTURE 31
648 VAGINAL HAEMORRHAGE 31
649 CEREBRAL INFARCTION 30
650 ELECTROENCEPHALOGRAM ABNORMAL 30
651 FACE OEDEMA 30
652 FEEDING DISORDER 30
653 FEELING OF DESPAIR 30
654 INJECTION SITE MASS 30
655 LIMB DISCOMFORT 30
656 PALLOR 30
657 RESPIRATORY DISORDER 30
658 STOMATITIS 30
659 TIC 30
660 VENTRICULAR SEPTAL DEFECT 30
661 BLINDNESS 29
662 BLOOD CALCIUM INCREASED 29
663 BRAIN FOG 29
664 FRUSTRATION TOLERANCE DECREASED 29
665 GASTRITIS 29
666 GLOSSITIS 29
667 HAEMORRHOIDS 29
668 HEAD DISCOMFORT 29
669 HYPERAMMONAEMIC ENCEPHALOPATHY 29
670 HYPERSEXUALITY 29
671 HYPERTRIGLYCERIDAEMIA 29
672 INCOHERENT 29
673 INITIAL INSOMNIA 29
674 INJECTION SITE ERYTHEMA 29
675 POSTURE ABNORMAL 29
676 PSYCHOMOTOR RETARDATION 29
677 PULMONARY HYPERTENSION 29
678 REBOUND EFFECT 29
679 RED BLOOD CELL SEDIMENTATION RATE INCREASED 29
680 REFUSAL OF TREATMENT BY PATIENT 29
681 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 29
682 WRONG PATIENT RECEIVED PRODUCT 29
683 ATRIOVENTRICULAR BLOCK COMPLETE 28
684 BLOOD LACTATE DEHYDROGENASE INCREASED 28
685 BLOOD POTASSIUM DECREASED 28
686 BLOOD SODIUM INCREASED 28
687 CEREBELLAR SYNDROME 28
688 EAR INFECTION 28
689 EAR PAIN 28
690 EJECTION FRACTION DECREASED 28
691 EOSINOPHIL COUNT INCREASED 28
692 FLAT AFFECT 28
693 HEMIPARESIS 28
694 IMPAIRED QUALITY OF LIFE 28
695 JOINT STIFFNESS 28
696 LIBIDO DECREASED 28
697 PANIC DISORDER 28
698 PHOTOSENSITIVITY REACTION 28
699 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 28
700 POSTURAL TREMOR 28
701 PREMATURE DELIVERY 28
702 SEDATION COMPLICATION 28
703 SKIN BURNING SENSATION 28
704 BACTERIAL INFECTION 27
705 BLOOD PRESSURE FLUCTUATION 27
706 CAMPTOCORMIA 27
707 CARDIOGENIC SHOCK 27
708 DIALYSIS 27
709 ELECTROCARDIOGRAM T WAVE INVERSION 27
710 GALLBLADDER DISORDER 27
711 HIP FRACTURE 27
712 HYPERKINESIA 27
713 NEURALGIA 27
714 OBSESSIVE THOUGHTS 27
715 OLIGURIA 27
716 ORAL CANDIDIASIS 27
717 SCHIZOAFFECTIVE DISORDER BIPOLAR TYPE 27
718 ACUTE MYOCARDIAL INFARCTION 26
719 ASTERIXIS 26
720 ENERGY INCREASED 26
721 EXTRA DOSE ADMINISTERED 26
722 EYE SWELLING 26
723 FOOT FRACTURE 26
724 GRAND MAL CONVULSION 26
725 HEART RATE IRREGULAR 26
726 HEPATIC FUNCTION ABNORMAL 26
727 HYPOACUSIS 26
728 LUNG NEOPLASM 26
729 PERSECUTORY DELUSION 26
730 PRESCRIBED UNDERDOSE 26
731 PRODUCT ADMINISTRATION ERROR 26
732 PRODUCTIVE COUGH 26
733 RESPIRATORY TRACT INFECTION 26
734 THROAT IRRITATION 26
735 UPPER LIMB FRACTURE 26
736 ACTION TREMOR 25
737 ANOSOGNOSIA 25
738 ATRIOVENTRICULAR BLOCK 25
739 BLEPHAROSPASM 25
740 CIRCULATORY COLLAPSE 25
741 DEAFNESS 25
742 DRUG PRESCRIBING ERROR 25
743 EYE PRURITUS 25
744 FLIGHT OF IDEAS 25
745 FREQUENT BOWEL MOVEMENTS 25
746 MENORRHAGIA 25
747 MUSCLE SPASTICITY 25
748 NEONATAL RESPIRATORY DISTRESS SYNDROME 25
749 NEPHROTIC SYNDROME 25
750 PAROXYSMAL PERCEPTUAL ALTERATION 25
751 PSORIATIC ARTHROPATHY 25
752 RESPIRATION ABNORMAL 25
753 RESTING TREMOR 25
754 SEPTIC SHOCK 25
755 SLOW SPEECH 25
756 TOXIC EPIDERMAL NECROLYSIS 25
757 ABULIA 24
758 ANGINA PECTORIS 24
759 APHONIA 24
760 ATTENTION DEFICIT/HYPERACTIVITY DISORDER 24
761 BLOOD GLUCOSE FLUCTUATION 24
762 CONSCIOUSNESS FLUCTUATING 24
763 DRUG SCREEN POSITIVE 24
764 DYSGRAPHIA 24
765 ELECTROLYTE IMBALANCE 24
766 FRACTURE 24
767 ILEUS PARALYTIC 24
768 IRON DEFICIENCY 24
769 KIDNEY INFECTION 24
770 LOSS OF EMPLOYMENT 24
771 MENSTRUATION IRREGULAR 24
772 MIOSIS 24
773 NEOPLASM MALIGNANT 24
774 PARTIAL SEIZURES 24
775 PERIPHERAL COLDNESS 24
776 SCREAMING 24
777 TEMPERATURE REGULATION DISORDER 24
778 ABDOMINAL PAIN LOWER 23
779 ANAL INCONTINENCE 23
780 ATELECTASIS 23
781 BODY MASS INDEX INCREASED 23
782 CEREBRAL HAEMORRHAGE 23
783 COMA SCALE ABNORMAL 23
784 CONDUCTION DISORDER 23
785 CYANOSIS 23
786 DEPENDENCE 23
787 DIFFERENTIAL WHITE BLOOD CELL COUNT ABNORMAL 23
788 HYPOKINETIC DYSARTHRIA 23
789 IMMUNE SYSTEM DISORDER 23
790 INCORRECT ROUTE OF DRUG ADMINISTRATION 23
791 INFUSION RELATED REACTION 23
792 LEFT VENTRICULAR HYPERTROPHY 23
793 PANIC REACTION 23
794 PRESYNCOPE 23
795 PULSE ABNORMAL 23
796 QUALITY OF LIFE DECREASED 23
797 SELF-DESTRUCTIVE BEHAVIOUR 23
798 SKIN CANCER 23
799 SKIN LESION 23
800 STREPTOCOCCAL INFECTION 23
801 ACCIDENTAL DEATH 22
802 ANAPHYLACTIC REACTION 22
803 ANKLE FRACTURE 22
804 BIPOLAR II DISORDER 22
805 CAESAREAN SECTION 22
806 CHOLESTASIS 22
807 CLAUSTROPHOBIA 22
808 DEVELOPMENTAL DELAY 22
809 GASTROENTERITIS VIRAL 22
810 HAEMATURIA 22
811 INCORRECT DRUG ADMINISTRATION DURATION 22
812 LIMB INJURY 22
813 MITRAL VALVE INCOMPETENCE 22
814 MULTIPLE FRACTURES 22
815 MUSCLE ATROPHY 22
816 ORAL PAIN 22
817 PHOTOPSIA 22
818 RASH MACULAR 22
819 RESPIRATORY RATE INCREASED 22
820 SLEEP-RELATED EATING DISORDER 22
821 SPEECH DISORDER DEVELOPMENTAL 22
822 STARING 22
823 SYDENHAM^S CHOREA 22
824 TORTICOLLIS 22
825 VENTRICULAR TACHYCARDIA 22
826 VITAMIN D DECREASED 22
827 WEIGHT FLUCTUATION 22
828 ASPIRATION 21
829 ATRIOVENTRICULAR BLOCK FIRST DEGREE 21
830 BLUNTED AFFECT 21
831 CENTRAL NERVOUS SYSTEM LESION 21
832 DRUG EFFECT LESS THAN EXPECTED 21
833 EXTRASYSTOLES 21
834 FEBRILE NEUTROPENIA 21
835 FEELINGS OF WORTHLESSNESS 21
836 FOAMING AT MOUTH 21
837 FUNGAL INFECTION 21
838 HEPATOMEGALY 21
839 HUMERUS FRACTURE 21
840 HYDRONEPHROSIS 21
841 HYPOAESTHESIA ORAL 21
842 HYPOCALCAEMIA 21
843 IMPAIRED SELF-CARE 21
844 INTENTIONAL DOSE OMISSION 21
845 INTERNATIONAL NORMALISED RATIO INCREASED 21
846 ORAL HERPES 21
847 OSCILLOPSIA 21
848 PAPILLARY THYROID CANCER 21
849 REBOUND PSYCHOSIS 21
850 SEXUALLY INAPPROPRIATE BEHAVIOUR 21
851 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 21
852 TENDONITIS 21
853 THYROIDITIS 21
854 TOOTH DISORDER 21
855 ABORTION SPONTANEOUS 20
856 ANORGASMIA 20
857 BLOOD URINE PRESENT 20
858 BREAST PAIN 20
859 CARDIOVASCULAR DISORDER 20
860 CONGESTIVE CARDIOMYOPATHY 20
861 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 20
862 DRUG ERUPTION 20
863 DYSPNOEA EXERTIONAL 20
864 ECZEMA 20
865 ESSENTIAL TREMOR 20
866 EYE IRRITATION 20
867 FACIAL PARALYSIS 20
868 GLOSSODYNIA 20
869 HYPERCHOLESTEROLAEMIA 20
870 IMPULSE-CONTROL DISORDER 20
871 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 20
872 INJECTION SITE SWELLING 20
873 INTRUSIVE THOUGHTS 20
874 LANGUAGE DISORDER 20
875 MATERNAL DRUGS AFFECTING FOETUS 20
876 MUSCLE INJURY 20
877 PROCEDURAL PAIN 20
878 PRURITUS GENERALISED 20
879 RESPIRATORY DEPRESSION 20
880 SCAR 20
881 TEMPERATURE INTOLERANCE 20
882 TENSION 20
883 THROAT TIGHTNESS 20
884 THYROID FUNCTION TEST ABNORMAL 20
885 TOOTHACHE 20
886 AUTOIMMUNE THYROIDITIS 19
887 BLOOD GLUCOSE ABNORMAL 19
888 BONE DISORDER 19
889 BREAST CANCER 19
890 BURSITIS 19
891 CORONARY ARTERY DISEASE 19
892 FAILURE TO SUSPEND MEDICATION 19
893 FEELING GUILTY 19
894 HIRSUTISM 19
895 HYPERACUSIS 19
896 HYPOSPADIAS 19
897 LIVER FUNCTION TEST INCREASED 19
898 LUNG DISORDER 19
899 MALNUTRITION 19
900 MUSCLE CONTRACTURE 19
901 MYOCARDIAL ISCHAEMIA 19
902 OCULAR HYPERAEMIA 19
903 PARATHYROID TUMOUR BENIGN 19
904 POLYHYDRAMNIOS 19
905 PRODUCT AVAILABILITY ISSUE 19
906 RECTAL PROLAPSE 19
907 THERAPY CHANGE 19
908 ACUTE HEPATIC FAILURE 18
909 ACUTE RESPIRATORY DISTRESS SYNDROME 18
910 ADVERSE REACTION 18
911 ALCOHOLISM 18
912 AMBLYOPIA 18
913 ANAPHYLACTIC SHOCK 18
914 BONE LOSS 18
915 BREAST ENLARGEMENT 18
916 CHROMATURIA 18
917 CLEAR CELL RENAL CELL CARCINOMA 18
918 COLITIS 18
919 DYSPRAXIA 18
920 EXPIRED PRODUCT ADMINISTERED 18
921 FAECES DISCOLOURED 18
922 FLUID INTAKE REDUCED 18
923 FOETAL GROWTH RESTRICTION 18
924 FORMICATION 18
925 HEPATITIS C 18
926 HERNIA 18
927 HICCUPS 18
928 IMPAIRED HEALING 18
929 INABILITY TO AFFORD MEDICATION 18
930 JOINT DISLOCATION 18
931 LYMPHOCYTE COUNT INCREASED 18
932 MENOPAUSE 18
933 MONOCYTE COUNT INCREASED 18
934 MULTIPLE DRUG OVERDOSE 18
935 PAIN IN JAW 18
936 PHOTOPHOBIA 18
937 POLYNEUROPATHY 18
938 SCIATICA 18
939 SYRINGE ISSUE 18
940 THYROTOXIC CRISIS 18
941 TRICUSPID VALVE INCOMPETENCE 18
942 ADULTERATED PRODUCT 17
943 ALCOHOL ABUSE 17
944 BLOOD PRESSURE SYSTOLIC INCREASED 17
945 BORDERLINE PERSONALITY DISORDER 17
946 CANDIDA INFECTION 17
947 CHOREA 17
948 CORONAVIRUS INFECTION 17
949 CROHN^S DISEASE 17
950 DENTAL CARIES 17
951 DEVICE BREAKAGE 17
952 DYSTONIC TREMOR 17
953 EMOTIONAL POVERTY 17
954 HYPERTRANSAMINASAEMIA 17
955 LOSS OF LIBIDO 17
956 MUSCULOSKELETAL DISORDER 17
957 MYOCLONIC EPILEPSY 17
958 NICOTINE DEPENDENCE 17
959 NO THERAPEUTIC RESPONSE 17
960 OSMOTIC DEMYELINATION SYNDROME 17
961 OVARIAN CYST 17
962 PREGNANCY 17
963 PRODUCT TAMPERING 17
964 SELF INJURIOUS BEHAVIOUR 17
965 SMALL INTESTINAL OBSTRUCTION 17
966 SNORING 17
967 THROMBOTIC THROMBOCYTOPENIC PURPURA 17
968 TOOTH INJURY 17
969 VARICOSE VEIN 17
970 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 16
971 ANKYLOSING SPONDYLITIS 16
972 ANTICONVULSANT DRUG LEVEL INCREASED 16
973 ATRIOVENTRICULAR BLOCK SECOND DEGREE 16
974 BLOOD CALCIUM DECREASED 16
975 BLOOD CHOLESTEROL ABNORMAL 16
976 BLOOD PRESSURE ABNORMAL 16
977 BLOOD TEST ABNORMAL 16
978 BRAIN OEDEMA 16
979 CEREBRAL DISORDER 16
980 COLD SWEAT 16
981 DERMATITIS ATOPIC 16
982 DISTURBANCE IN SOCIAL BEHAVIOUR 16
983 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 16
984 ECHOLALIA 16
985 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 16
986 EXPOSURE TO TOXIC AGENT 16
987 FIBROSIS 16
988 FOETAL DEATH 16
989 GINGIVAL BLEEDING 16
990 HYPOTONIA NEONATAL 16
991 INTRACRANIAL PRESSURE INCREASED 16
992 LACERATION 16
993 LACRIMATION INCREASED 16
994 LOW DENSITY LIPOPROTEIN INCREASED 16
995 OESOPHAGITIS 16
996 PERFORMANCE STATUS DECREASED 16
997 POLYCYSTIC OVARIES 16
998 POST PROCEDURAL COMPLICATION 16
999 PRODUCT ADHESION ISSUE 16